Bladder: Risk and prognostic factors - A pathologist's perspective
Drug Resistance, Neoplasm
Gene Expression Profiling
Neoplasms, Germ Cell and Embryonal
Morphology remains a power tool to help predict the risk of recurrence, progression, and even response to therapy in bladder cancer. Nevertheless, more work is needed to refine and standardize criteria and terminology. Novel molecular tools may reveal prognostic factors, but these techniques must be compared with standard morphologic and clinical markers by performing multivariate analysis in a prospective fashion.